CNS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 380 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 376-380 of 380 matching filings.

Per page
25
Current page
16
1-A/A File 024-10855

1-A/A filing

Filing date
10 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
1-A File 024-10855

1-A filing

Filing date
15 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
C-U File 020-24084

C-U filing

Filing date
15 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DOS File 367-00144

DOS filing

Filing date
17 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
C File 020-24084

C filing

Filing date
13 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .